Supplementary Figure 4 from PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN
作者
Abdallah Flaifel,Wanling Xie,David A. Braun,Miriam Ficial,Ziad Bakouny,Amin H. Nassar,Rebecca B. Jennings,Bernard Escudier,Daniel J. George,Robert J. Motzer,Michael J. Morris,Thomas Powles,Evelyn N. Wang,Ying Huang,Gordon J. Freeman,Toni K. Choueiri,Sabina Signoretti